Aalto Bio Reagents - Ownership and Business Overview

Life ScienceCompany

Aalto Bio Reagents Ownership

Who owns Aalto Bio Reagents?

Aalto Bio Reagents is owned by Biosynth. It was acquired on May 26, 2022.

Aalto Bio Reagents Business Overview

Where is Aalto Bio Reagents headquartered?

Aalto Bio Reagents is headquartered in Dublin, Ireland.

What sector is Aalto Bio Reagents in?

Aalto Bio Reagents is a life science company.

When was Aalto Bio Reagents founded?

Aalto Bio Reagents was founded in 1978.

Life Science M&A Summary in 2022

Out of 60 sectors in the Mergr database, life science ranked 7 in number of deals in 2022. The largest life science acquisition in 2022 was Horizon Therapeutics Public Limited Company - which was acquired by Amgen for $27.8B.

Subscribe to Mergr to view all 299 acquisitions of life science companies in 2022, including 37 acquisitions by private equity firms, and 262 by strategics.

Aalto Bio Reagents

Aalto Bio Reagents Ltd.

Unit A6 Nutgrove Office Park,
Dublin, D14 DX26
Ireland,
+353-1-4900685
www.aaltobioreagents.com

Aalto Bio Reagents is a developer and provider of biological materials to the in-vitro diagnostic (IVD) and vaccine development industry in emerging diseases. Aalto Bio Reagents was founded in 1978 and is based in Dublin, Ireland.


 Subscribe to unlock this and 215,016
investor and company profiles

Sign-up today to get full access

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More

What's Mergr?

Mergr is a user-friendly database designed to simplify the complex world of private equity and M&A for busy professionals.

We created Mergr to eliminate the challenge of tracking company acquisitions, sales, and ownership, providing clear insights into investment firms and their activities. For example, explore a company's M&A activity, ownership history, and connections - organized to help you uncover opportunities and make informed decisions.

With Mergr, gain access to a comprehensive, interconnected web of transactions, investors, companies, and advisors - all in one place.

Mergr, the Easiest-to-Use PE and M&A DB


Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.7K Private Equity Firms
  • 208K M&A Transactions
  • 210K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.7K M&A Advisors
    (Investment Banks and Law Firms)
  • 81K M&A Contacts
    (PE and M&A Advisors)

What next?

Get Full Access

Full access to Mergr's investor, acquirer, and transaction data starts here.

Related Lists for Aalto Bio Reagents

Life Science Companies